Literature DB >> 7826359

Interaction of cholesterol-crystallization-promoting proteins with vesicles.

M A de Bruijn1, B G Goldhoorn, A I Zijlstra, G N Tytgat, A K Groen.   

Abstract

In this study, the interaction of mucin and concanavalin A-binding proteins isolated from human bile with cholesterol/phospholipid vesicles was investigated. Using resonance energy transfer assays originally developed by Struck, Hoekstra and Pagano [(1981) Biochemistry 20, 4093-4099], no significant protein-induced fusion or aggregation of vesicles was demonstrated. Instead of fusion, these proteins induced destabilization of cholesterol/phospholipid vesicles, as monitored by release of entrapped carboxyfluorescein. A good correlation (rho = 0.81) was obtained between the extent of leakage and the nucleation-promoting activity of the concanavalin A-binding proteins. We conclude that aggregation or fusion of cholesterol/phospholipid vesicles is not an obligatory step in cholesterol crystallization. Biliary protein-induced crystallization seems to be preceded by vesicle disruption.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7826359      PMCID: PMC1136434          DOI: 10.1042/bj3050093

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Rapid vesicle formation and aggregation in abnormal human biles. A time-lapse video-enhanced contrast microscopy study.

Authors:  Z Halpern; M A Dudley; A Kibe; M P Lynn; A C Breuer; R T Holzbach
Journal:  Gastroenterology       Date:  1986-04       Impact factor: 22.682

2.  Contribution of vesicular and micellar carriers to cholesterol transport in human bile.

Authors:  G J Sömjen; T Gilat
Journal:  J Lipid Res       Date:  1985-06       Impact factor: 5.922

3.  Factors affecting cholesterol monohydrate crystal nucleation time in model systems of supersaturated bile.

Authors:  A Kibe; M A Dudley; Z Halpern; M P Lynn; A C Breuer; R T Holzbach
Journal:  J Lipid Res       Date:  1985-09       Impact factor: 5.922

4.  Purification of a trypsin-insensitive fragment of spectrin from human erythrocyte membranes.

Authors:  M Hanspal; G B Ralston
Journal:  Biochim Biophys Acta       Date:  1981-07-28

5.  A non-micellar mode of cholesterol transport in human bile.

Authors:  G J Somjen; T Gilat
Journal:  FEBS Lett       Date:  1983-06-13       Impact factor: 4.124

6.  Vesicle aggregation in model systems of supersaturated bile: relation to crystal nucleation and lipid composition of the vesicular phase.

Authors:  Z Halpern; M A Dudley; M P Lynn; J M Nader; A C Breuer; R T Holzbach
Journal:  J Lipid Res       Date:  1986-03       Impact factor: 5.922

7.  Isolation and partial characterization of cholesterol pronucleating hydrophobic glycoproteins associated to native biliary vesicles.

Authors:  J F Miquel; L Núñez; A Rigotti; L Amigo; E Brandan; F Nervi
Journal:  FEBS Lett       Date:  1993-02-22       Impact factor: 4.124

8.  Hydrophobic binding properties of bovine gallbladder mucin.

Authors:  B F Smith; J T LaMont
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

9.  Partial characterization of a nonmicellar system of cholesterol solubilization in bile.

Authors:  S P Lee; H Z Park; H Madani; E W Kaler
Journal:  Am J Physiol       Date:  1987-03

10.  Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease.

Authors:  K R Holan; R T Holzbach; R E Hermann; A M Cooperman; W J Claffey
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

View more
  2 in total

1.  Quantitative assessment of comparative potencies of cholesterol-crystal-promoting factors: relation to mechanistic characterization.

Authors:  T Nishioka; S Tazuma; G Yamashita; G Kajiyama
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

2.  Partial replacement of bile salts causes marked changes of cholesterol crystallization in supersaturated model bile systems.

Authors:  T Nishioka; S Tazuma; G Yamashita; G Kajiyama
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.